200 Participants Needed

Medically Tailored Meals + Lifestyle Intervention for HIV and Type 2 Diabetes

(FAME-H Trial)

KR
Overseen ByKatharine Ricks, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of North Carolina, Chapel Hill
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how specialized meal plans and lifestyle changes can assist people living with HIV and type 2 diabetes, or those at risk, especially if they face food insecurity. Participants will receive meals tailored to their medical needs and lifestyle coaching over the phone to determine if this combination improves health more than receiving meals alone. This study suits individuals diagnosed with HIV, those with type 2 diabetes or at risk, and those experiencing food insecurity affecting daily life. As an unphased trial, it offers a unique opportunity to contribute to research that could lead to better health strategies for managing HIV and diabetes.

Will I have to stop taking my current medications?

The trial information does not specify if you need to stop taking your current medications. However, if you are using medications that affect blood sugar intermittently, you may not be eligible to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research shows that meals specifically designed for medical needs and focused lifestyle changes are generally safe. Studies have found that providing these meals to patients with diabetes not only improves their diet and access to food but also reduces hospital visits by up to 50%. Using these meals and lifestyle changes together is well-tolerated, with no major side effects reported in past studies. These results provide strong evidence for the safety of this treatment approach.12345

Why are researchers excited about this trial?

Researchers are excited about the Medically Tailored Meals (MTM) combined with Intensive Lifestyle Intervention (ILI) for HIV and Type 2 Diabetes because it takes a personalized approach to treatment. Unlike standard care, which often involves medication management and general dietary advice, this treatment provides weekly home-delivered meals specifically tailored to each individual's medical needs. It also includes a comprehensive 20-session telephone lifestyle program, which helps participants build skills and behaviors to sustain health benefits even after the intervention ends. This holistic method not only targets nutrition but also emphasizes long-term lifestyle changes, offering a unique and potentially more effective way to manage these conditions.

What evidence suggests that this trial's treatments could be effective for HIV and Type 2 Diabetes?

Research has shown that specially prepared meals, when combined with a focused lifestyle program, can greatly improve health for people with HIV and Type 2 Diabetes (T2DM). In this trial, participants in one arm will receive Medically Tailored Meals (MTM) combined with an Intensive Lifestyle Intervention (ILI), which includes weekly home meal delivery and a 20-session telephone lifestyle change program. Studies have found that such combined interventions can reduce hospital visits by up to 50% and lower overall healthcare use. One study showed that these meals significantly improved patients' diet quality, increasing their Healthy Eating Index score by 31.4 points. Additionally, providing these meals to diabetic patients improved their diet and food security. These findings suggest that using these meals along with lifestyle changes could effectively manage both HIV and T2DM, especially for those who struggle to get enough food.12346

Who Is on the Research Team?

SA

Seth A Berkowitz, MD, MPH

Principal Investigator

University of North Carolina, Chapel Hill

Are You a Good Fit for This Trial?

Adults over 18, who speak English and are not planning to move for a year, can join this trial if they're food insecure with HIV and Type 2 Diabetes or at high risk of it. They must be able to control their diet and consent to all study activities. Pregnant individuals, those in similar studies recently, with certain illnesses or drug misuse cannot participate.

Inclusion Criteria

No plans to move from the area for at least 1 year
Willing and able to provide written informed consent and participate in all study activities
English speaking
See 6 more

Exclusion Criteria

Pregnancy/breastfeeding or intended pregnancy in the next year
You have participated in a study about diabetes, nutrition, or weight in the past year.
Lack of telephone
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive medically tailored meals and intensive lifestyle intervention or standard nutrition education for 12 months

12 months
Weekly home meal delivery

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

What Are the Treatments Tested in This Trial?

Interventions

  • MTM + ILI
  • Standard MTM
Trial Overview The trial is testing whether specially prepared meals plus an intensive lifestyle program (MTM + ILI) help adults with HIV and diabetes better than the usual medical treatment for diabetes alone. Participants will be randomly assigned to one of these two groups.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Medically Tailored Meal (MTM) + Intensive Lifestyle Intervention (ILI)Experimental Treatment1 Intervention
Group II: Standard MTMActive Control1 Intervention

MTM + ILI is already approved in United States for the following indications:

🇺🇸
Approved in United States as Medically Tailored Meals and Intensive Lifestyle Intervention for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of North Carolina, Chapel Hill

Lead Sponsor

Trials
1,588
Recruited
4,364,000+

Community Servings

Collaborator

Trials
4
Recruited
510+

Community Servings

Collaborator

Trials
4
Recruited
510+

Massachusetts General Hospital

Collaborator

Trials
3,066
Recruited
13,430,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+

Published Research Related to This Trial

Optimizing nutritional status through individualized medical nutrition therapy and education is crucial for the health care of people living with HIV, as it supports their overall health and treatment outcomes.
Despite advancements in HIV treatment leading to longer survival rates, challenges such as food insecurity and nutrition-related complications remain significant, highlighting the need for registered dietitians to play an integral role in managing these issues.
Position of the American Dietetic Association: Nutrition Intervention and Human Immunodeficiency Virus Infection.Fields-Gardner, C., Campa, A.[2019]
A study involving 63 HIV-infected adults showed that a locally made ready-to-use therapeutic food (RUTF) was highly acceptable, with 95% participation, and led to significant weight gain and improved physical activity over three months.
After three months, 73.3% of participants gained weight, with average increases of 3.0 kg in weight and 25.4 mm in mid-upper-arm circumference, indicating the RUTF's effectiveness in addressing malnutrition in this population.
Acceptability and effectiveness of chickpea sesame-based ready-to-use therapeutic food in malnourished HIV-positive adults.Bahwere, P., Sadler, K., Collins, S.[2022]
The HIV-Care-Program, which included nutrition and lifestyle counseling over 6 months, significantly reduced the decline in CD4 counts in HIV-infected patients compared to usual care, with a drop of only 46.3 cells in the intervention group versus 129 cells in the control group.
The program also delayed the initiation of antiretroviral therapy (ARV) by about 1 month longer in the intervention group, suggesting it can help manage healthcare resources more effectively while improving patient health outcomes.
Effects of an HIV-Care-Program on immunological parameters in HIV-positive patients in Yaoundé, Cameroon: a cluster-randomized trial.Nkengfack, GN., Torimiro, JN., Ngogang, J., et al.[2021]

Citations

NCT05026723 | Food as Medicine for HIV and DiabetesThe goal for this project is to test whether this medically tailored meal intervention can lead to improvements in weight, hemoglobin A1c, and in patient- ...
Assessing the impact of medically tailored meals and ...Pilot studies of MTM, including services provided by our local meal provider, demonstrated up to 50% fewer hospitalizations, reduced healthcare utilization and ...
Effect of an Intensive Food-as-Medicine Program on Health ...A randomized crossover study found that delivering medically tailored meals to patients with diabetes improved diet and food security, and a ...
Medically Tailored Meals to Address the Health ...Quantitative evaluation revealed that receiving these meals substantially improved diet quality (difference in the Healthy Eating Index score, 31.4 points [3 SD]) ...
Evidence Assessment Library - Medically Tailored MealsThis assessment synthesizes the results of studies on medically tailored meals across three domains of measurement:.
Food as Medicine for HIV and Diabetes Clinical Trial ...Medically tailored meal home delivery programs relieve food insecurity for people with HIV. Medically tailored meals emerged to treat food insecurity among ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security